Comparison of alcohol-dependent patients at a gastroenterological and a psychiatric ward according to the lesch alcoholism typology: Implications for treatment

Alcohol and Alcoholism

Volumn 45, Issue 6, 2010, Pages 534-540

  Vyssoki, Benjamin ^a   Steindl Munda, Petra ^a   Ferenci, Peter ^a   Walter, Henriette ^a   Höfer, Peter ^a   Blüml, Victor ^a   Friedrich, Fabian ^a   Kogoj, Dagmar ^a   Lesch, Otto M ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ADULT; ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ALCOHOLISM; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GASTROENTEROLOGY; HUMAN; LESCH ALCOHOLISM TYPOLOGY; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; PRIORITY JOURNAL; PSYCHIATRIC DEPARTMENT; RELAPSE; STRUCTURED INTERVIEW; SUICIDAL IDEATION; TREATMENT INDICATION; TREATMENT PLANNING;

ADULT; ALCOHOLISM; DECISION TREES; FEMALE; GASTROENTEROLOGY; GASTROINTESTINAL DISEASES; HOSPITALIZATION; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; PSYCHIATRIC DEPARTMENT, HOSPITAL; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 78149475113     PISSN: 07350414     EISSN: 14643502     Source Type: Journal    
DOI: 10.1093/alcalc/agq059     Document Type: Article

References (42)

1. Addolorato G, Leggio L, Ferrulli A et al. (2007) Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study. Lancet 370:1915-22.
2. Ahboucha S, Butterworth RF. (2004) Pathophysiology of hepatic encephalopathy: a new look at GABA from the molecular stand-point. Metab Brain Dis 19:331-43.
3. Ahboucha S, Butterworth RF. (2005) Role of endogenous benzo-diazepine ligands and their GABA-A-associated receptors in hepatic encephalopathy. Metab Brain Dis 20:425-37.
4. American Psychiatric Association. (2000) Diagnostic and Statistical Manual of Mental Disorders (IV-TR), 4th edn, text revised. Washington, DC: American Psychiatric Association.
5. Arolt V, Driessen M. (1996) Alcoholism and psychiatric comorbidity in general hospital inpatients. Gen Hosp Psychiatry 18:271-7.
6. Arolt V, Driessen M, Schürmann A. (1995) Incidence and treatment requirements of alcoholism in internal medicine and hospital patients. Fortschr Neurol Psychiatr 63:283-8.
7. Berlakovich GA, Steininger R, Herbst F et al. (1994) Efcacy of liver transplantation for alcoholic cirrhosis with respect to recidivism and compliance. Transplantation 58:560-5.
8. Berlakovich GA, Windhager T, Freundorfer E et al. (1999) Carbohydrate decient transferrin for detection of alcohol relapse after orthotopic liver transplantation for alcoholic cirrhosis. Transplantation 67:1231-5.
9. Bleich S, Bayerlein K, Reulbach U et al. (2004) Homocysteine levels in patients classied according to Lesch's typology. Alcohol Alcohol 39:493-8.
10. Blondell RD. (2005) Ambulatory detoxication of patients with alcohol dependence. Am Fam Physician 71:495-502.
11. Butterworth RF. (2008) Pathophysiology of hepatic encephalopathy: the concept of synergism. Hepatol Res 38:116-21.
12. Diehl A, Nakovics H, Croissant Bet al. (2009) Consultation-liaison psychiatry in general hospitals: improvement in physicians' detection rates of alcohol use disorders. Psychosomatics 50:599-604.
13. Flensborg-Madsen T, Mortensen EL, Knop J et al. (2009) Comorbidity and temporal ordering of alcohol use disorders and other psychiatric disorders: results from a Danish register-based study. Compr Psychiatry 50:307-14.
14. Hasin DS, Stinson FS, Ogburn E et al. (2007) Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 64:830-42.
15. Hillemacher T, Bleich S. (2008) Neurobiology and treatment in alcoholism-recent ndings regarding Lesch's typology of alcohol dependence. Alcohol Alcohol 43:341-6.
16. Jones EA, Schafer DF, Ferenci P et al. (1984) The GABA hypothesis of the pathogenesis of hepatic encephalopathy: current status. Yale J Biol Med 57:301-16.
17. Jones EA, Basile AS, Yurdaydin C et al. (1993) Do benzodiazepine ligands contribute to hepatic encephalopathy? Adv Exp Med Biol 341:57-69.
18. Kamath PS, Wiesner RH, Malinchoc M et al. (2001) A model to predict survival in patients with end-stage liver disease. Hepatology 33:464-70.
19. Kiefer F, Barocka A. (1999) Secondary depression in weaned alcoholics: implications of Lesch's typology of chronic alcoholism. Alcohol Alcohol 34:916-7.
20. Kiefer F, Helwig H, Tarnaske T et al. (2005) Pharmacological relapse prevention of alcoholism: clinical predictors of outcome. Eur Addict Res 11:83-91.
21. Leggio L, Kenna GA, Fenton M et al. (2009) Typologies of alcohol dependence. From Jellinek to genetics and beyond. Neuropsychol Rev 19:115-29.
22. Lesch OM, Walter H. (1996) Subtypes of alcoholism and their role in therapy. Alcohol Alcohol 31:63-7.
23. Lesch OM, Walter H. (2009) Alkohol und Tabak, Medizinische und soziologische Aspkete von Gebrauch, Missbrauch und Abhängigkeit, Vol. 1. Vienna: Springer.
24. Lesch OM, Dietzel M, Musalek M. (1988) The course of alcoholism. Long-term prognosis in different types. Forensic Sci Int 36:121-38.
25. Lesch OM, Kefer J, Lentner S et al. (1990) Diagnosis of chronic alcoholism-classicatory problems. Psychopathology 23:88-96.
26. Lesch OM, Riegler A, Gutierrez K et al. (2001) The European acamprosate trials: conclusions for research and therapy. J Biomed Sci 8:89-95.
27. Lucey MR. (2009) Management of alcoholic liver disease. Clin Liver Dis 13:267-75.
28. Mayo-Smith MF. (1997) Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. JAMA 278:144-51.
29. Mullen KD, Szauter KM, Kaminsky-Russ K. (1990) "Endogenous" benzodiazepine activity in body uids of patients with hepatic encephalopathy. Lancet 336:81-3.
30. Nyblom H, Berggren U, Balldin J et al. (2004) High AST/ALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking. Alcohol Alcohol 39:336-9.
31. Pombo S, Lesch OM. (2009) The alcoholic phenotypes among different multidimensional typologies: similarities and their classication procedures. Alcohol Alcohol 44:46-54.
32. Proudfoot H, Teesson M. (2009) The association of alcohol dependence with general practice attendance. Drug Alcohol Rev 28:154-9.
33. Rehm J, Room R, Graham K et al. (2003) The relationship of average volume of alcohol consumption and patterns of drinking to burden of disease: an overview. Addiction 98:1209-28.
34. Saitz R, O'Malley SS. (1997) Pharmacotherapies for alcohol abuse. Withdrawal and treatment. Med Clin North Am 81:881-907.
35. Smith S, White J, Nelson C et al. (2006) Severe alcohol-induced liver disease and the alcohol dependence syndrome. Alcohol Alcohol 41:274-7.
36. Srikurja W, Kyulo N, Runyon B et al. (2005) MELD Score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patientes with alcoholisc hepatitis. J Hepatol 42:700-706.
37. Teesson M, Slade T, Mills K. (2009) Comorbidity in Australia: ndings of the 2007 National Survey of Mental Health and Wellbeing. Aust N Z J Psychiatry 43:606-14.
38. Walter H, Gutierrez K, Ramskogler K et al. (2003) Gender-specic differences in alcoholism: implications for treatment. Arch Womens Ment Health 6:253-8.
39. Walter H, Ramskogler-Skala K, Dvorak A et al. (2006) Glutamic acid in withdrawal and weaning in patients classied according to Cloninger's and Lesch's typologies. Alcohol Alcohol 41:505-11.
40. Weaver MF, Hoffman HJ, Johnson RE et al. (2006) Alcohol with-drawal pharmacotherapy for inpatients with medical comorbidity. J Addict Dis 25:17-24.
41. World Health Organization. (1992) International Classication of Diseases, Tenth Revision. Geneva, Switzerland: World Health Organization.
42. Yang AL, Vadhavkar S, Singh G et al. (2008) Epidemiology of alcohol-related liver and pancreatic disease in the United States. Arch Intern Med 168:649-56.